MTOR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.62790020247417E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.61209999793854E-08 |
Normal-vs-Stage2 |
3.59050000000583E-05 |
Normal-vs-Stage3 |
3.16259999966206E-07 |
Normal-vs-Stage4 |
1.70084999999709E-05 |
Stage1-vs-Stage2 |
5.370800E-01 |
Stage1-vs-Stage3 |
3.256000E-01 |
Stage1-vs-Stage4 |
8.666200E-02 |
Stage2-vs-Stage3 |
8.389000E-01 |
Stage2-vs-Stage4 |
2.519200E-01 |
Stage3-vs-Stage4 |
2.394400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.32069996553008E-09 |
Normal-vs-AfricanAmerican |
2.10560000546423E-08 |
Normal-vs-Asian |
1.576730E-03 |
Caucasian-vs-AfricanAmerican |
8.170600E-01 |
Caucasian-vs-Asian |
3.968400E-01 |
AfricanAmerican-vs-Asian |
3.747800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.43904937650086E-12 |
Normal-vs-Female |
1.193290E-04 |
Male-vs-Female |
2.927800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.31290000041184E-07 |
Normal-vs-Extreme_Weight |
5.23799892349075E-11 |
Normal-vs-Obese |
7.46230000014947E-07 |
Normal-vs-Extreme_Obese |
2.556700E-03 |
Normal_Weight-vs-Extreme_Weight |
7.199400E-01 |
Normal_Weight-vs-Obese |
5.786400E-01 |
Normal_Weight-vs-Extreme_Obese |
7.481800E-01 |
Extreme_Weight-vs-Obese |
2.788600E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.539400E-01 |
Obese-vs-Extreme_Obese |
9.922200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.799500E-04 |
Normal-vs-Age(41-60Yrs) |
1.26229999786176E-08 |
Normal-vs-Age(61-80Yrs) |
7.84069997816772E-09 |
Normal-vs-Age(81-100Yrs) |
8.14599999676702E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.544200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.191200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.466300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.073580E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.739700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
5.55580000005662E-07 |
Normal-VS-Type2 PRCC |
5.04640000009715E-07 |
Normal-VS-KIRP CIMP |
7.356300E-04 |
Normal-VS-Unclassified PRCC |
1.240650E-03 |
Type1 PRCC-VS-Type2 PRCC |
4.213600E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.726400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.452800E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.743600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.362440E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.788600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.43960000271215E-08 |
Normal-vs-N1 |
2.31899999980634E-07 |
Normal-vs-N2 |
3.468000E-02 |
N0-vs-N1 |
9.537600E-01 |
N0-vs-N2 |
8.354800E-01 |
N1-vs-N2 |
8.184800E-01 |
|
|